Compass Financial Management LLC Takes Position in iShares U.S. Pharmaceuticals ETF $IHE

Compass Financial Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 5,627 shares of the company’s stock, valued at approximately $565,000.

A number of other hedge funds also recently modified their holdings of the stock. EFG International AG purchased a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at approximately $38,000. Assetmark Inc. increased its position in iShares U.S. Pharmaceuticals ETF by 203.9% in the fourth quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after buying an additional 312 shares during the last quarter. O Shaughnessy Asset Management LLC increased its position in iShares U.S. Pharmaceuticals ETF by 35.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after buying an additional 120 shares during the last quarter. Blueline Advisors LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $41,000. Finally, Accent Capital Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $42,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA IHE opened at $106.79 on Monday. The stock has a market capitalization of $1.71 billion, a PE ratio of 17.75 and a beta of 0.48. iShares U.S. Pharmaceuticals ETF has a one year low of $69.02 and a one year high of $108.66. The business’s fifty day moving average price is $100.41 and its 200-day moving average price is $92.84.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.